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Abstract  
 
Background 
 
Web-based programs (WBPs) offer potential as a medium for supporting weight loss, owing 
to their easy accessibility, anonymity and capacity for wide reach. However, further research 
is warranted to determine the shorter- and longer-term effects of these WBPs, not only in 
relation to weight loss, but other health outcomes and, specifically, to determine effects in 
comparison with a ‘true control’ group.  
 
Objective 
 
To evaluate the effects of a web-based component of a service ‘Imperative Health’ on weight 
loss in an overweight/obese population at high risk of cardiovascular disease (CVD) using a 
randomised controlled design and a ‘true control’ group.  
 
Methods 
 
Sixty-five overweight/obese adults at high risk of CVD were randomly allocated to one of 
two groups. Group one (n=32) were provided with the web-based program. This WBP 
supports positive dietary and physical activity changes and assists in managing weight and 
other cardiovascular risk factors. It combines objective monitoring of weight and physical 
activity with automated, tailored feedback. Group two were asked to continue with their usual 
self-care (n=33). Assessments were carried out face-to-face. The primary outcome was 
between-group change in weight at 3 months. Secondary outcomes included between-group 
change in anthropometric measurements, blood pressure, lipid measurements, physical 
activity and energy intake at 3, 6 and 12 months. Interviews were conducted to explore 
participants’ views of the WBP. 
 
Results 
 
Retention rates for the intervention and control groups at 3 months were (78% vs. 97%), at 6 
months (66% vs. 94%) and at 12 months (53% vs. 88%), respectively. Intention-to-treat 
analysis, using a single imputation method (baseline observation carried forward), revealed 
that the intervention group lost more weight relative to the control group at 3 months (-3.41 
kg vs. -0.52 kg; P<.001, respectively), at 6 months (-3.47 kg vs. -0.81; P=.02, respectively), 
but not at 12 months (-2.38 vs. -1.80 kg; P=.77). More intervention group participants 
compared with the control group lost 5% or more of their baseline body weight at 3 months 
(34.4% vs. 3.0%, P<.001) and 6 months (40.6% vs. 18.2%, P=.047), but not at 12 months 
(21.9% vs. 21.2%, P=.95). The intervention group showed improvements in total cholesterol 
(P=.003) and triglyceride (P=.003) concentrations, and adopted more positive dietary 
(P=.005) and physical activity (P=.03) behaviours for up to 3 months compared with the 
control group; however, these improvements were not sustained in the longer-term. 
 
Conclusions 
 
Although high levels of attrition were evident in the intervention group, this study provides 
evidence that this WBP can be used to initiate clinically relevant weight loss and lower CVD 
risk up to 3-6 months based on the proportion of participants losing 5% or more of their body 
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weight in the WBP group relative to the true control group. It also highlights a need for 
augmenting WBPs with further interventions, such as telephone, email or in-person support in 
the longer-term to enhance engagement and maintain these changes.  
Trial Registration 
 
ClinicalTrials.gov identifier: NCT01472276; 
http://clinicaltrials.gov/ct2/show/study/NCT01472276 
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Introduction 
 
The prevalence of obesity has been increasing progressively throughout the world [1]. 
Identifying effective and cost-effective treatment and prevention strategies is a top priority for 
all healthcare systems. Over the past few decades the internet has increasingly been used to 
deliver behavioural modification programs owing to its easy accessibility and anonymity, 
potential for wide reach and penetration, and its ability to provide a source of continuous 
support to large segments of the population [2,3,4]. 
 
There is growing evidence suggesting that the internet may be a viable medium for 
encouraging weight loss. However, several systematic reviews and meta-analysis, conducted 
in this area have found it difficult to draw definitive conclusions regarding its effectiveness 
owing to heterogeneity in study designs, methods employed and the lack of ‘true control’ 
groups used  [5,6,7,8,9]. Most of the evidence to date comes from randomised controlled 
trials (RCTs) conducted in the USA. Many only included short-term follow-up and lacked 
‘true control’ groups (no support provided), making it challenging to accurately evaluate the 
true effectiveness of web-based programs (WBPs). Instead, minimal support groups are often 
employed to help boost recruitment and decrease attrition, although this approach may 
attenuate the relationship between groups and limits the ability of the findings to inform cost-
effectiveness and healthcare models. Research is also limited regarding the effect of these 
WBPs on other health outcomes that co-exist with weight loss, such as cardiovascular disease 
(CVD) risk factors. Therefore, the aim of this study was to evaluate the effects of an 
interactive web-based component of a service called Imperative Health on weight loss 
(primary outcome) and CVD risk factors (secondary outcomes) in an overweight and obese 
population at high risk of CVD using a randomised controlled design and a ‘true control’ 
group. It was hypothesised that weight loss would be greater in the WBP intervention group 
compared to the usual care control group. 
 
Methods 
 
Recruitment 
 
Ethical approval was obtained from the Office for Research Ethics Committees Northern 
Ireland. The trial was registered (ClinicalTrials.gov identifier: NCT01472276) and is reported 
in accordance with the Consolidated Standards of Reporting Trials (CONSORT) - ehealth 
checklist (Multimedia Appendix 1) [10]. Participants were recruited from April to December 
2011 using posters in public places in the greater Belfast area, and intranet advertisements via 
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staff updates in the Belfast Health and Social Care Trust and Queen’s University Belfast 
(QUB). Patients from the Regional Centre for Diabetes and Endocrinology at the Royal 
Victoria Hospital Belfast were also sent a letter informing them about the study. Participants 
were eligible if they were aged over 18 years, had a BMI between 27 to 40 kg/m
2
, were 
inactive or moderately inactive assessed by the General Practice Physical Activity 
Questionnaire (GPPAQ) [11] and had one or more CVD risk factor: high blood pressure ≥ 
140/90 mmHg, cholesterol ≥ 5.0 mmol/l or type 2 diabetes. All participants were required to 
have access to the internet, email, and a telephone and were asked not to participate in another 
behavioural change weight loss program throughout the study period. Participants were 
excluded if they had established CVD, type 1 diabetes, were pregnant or consumed excessive 
amounts of alcohol. Computer literacy was not assessed. All participants at the screening 
appointment provided written informed consent. 
 
Study design 
 
After completion of the baseline assessments, conducted face-to-face, at the Regional Centre 
for Diabetes and Endocrinology at the Royal Victoria Hospital Belfast, participants were 
randomly allocated to one of two parallel groups (1:1 allocation ratio) using a block 
randomisation approach (block size = 10) with computer-generated numbers (figure 1). A 
researcher independent from the study prepared the randomisation schedule. Opaque sealed 
envelopes were used to conceal the sequence until groups were allocated. Participants were 
recruited and enrolled by the researcher, who was unaware of the randomisation schedule 
until after the baseline assessments when the sealed envelope containing the allocation 
outcome was opened by the participant. Group one (intervention group) was provided with 
the WBP known as Imperative Health, excluding telephone and email support and group two 
(control group) was requested to continue with their usual self and medical care. All 
participants were followed up 3 months, 6 months and 12 months after randomisation for 
assessment of primary and secondary outcomes. Based on a standard deviation of weight loss 
at 3 months of 3.0 kg, observed in a number of internet-based weight loss studies in the 
literature [12,13,14,15], it was estimated that a sample size of 60 (30 per group) would give 
the study 90% power at the 5% significance level to detect a difference of 2.6 kg between 
groups at the 3 month follow-up. Allowing for a 10% drop out rate at the first 3 month 
follow-up, it was aimed to recruit 66 participants. With only one researcher on the ground, it 
was not possible to blind the researcher or participants to group allocation but laboratory 
analysis was performed blind.  
 
Intervention (Imperative Health WBP) 
 
Imperative Health is a service, owned by AXA PPP Healthcare Limited, that consists of a 
WBP and human (email and telephone) support that assists in lifestyle change; with a 
particular focus on improving diet and nutrition, increasing physical activity and managing 
weight and other CVD risk factors. It combines objective monitoring of weight and physical 
activity with automated, tailored feedback and support by physiologists by telephone and 
email. Previous versions of this WBP have been evaluated by Hurling et al. [16,17] and Ware 
et al. [18]; this program has since been modified to be more relevant to individuals that have 
independent risk factors for CVD such as hypertension, dyslipidemia (high cholesterol and 
triglycerides) and type 2 diabetes. For this particular study only the WBP component of the 
service was evaluated in order to determine its specific impact, i.e. the human support 
(telephone and email) component of the service was removed for the purposes of this trial. 
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Initial set-up of Imperative Health (WBP) 
 
At the end of the baseline appointment the intervention group participants were provided with 
the Imperative Health package that contained the self-monitoring devices (Bluetooth enabled 
weighing scales and an accelerometer activity band) and basic written instructions to set up an 
online account at home. To access the online program participants were instructed to go to the 
Imperative health website [19] and enter a unique code to create their own personal password-
protected free account. To complete registration and to enable the setup of the monitoring 
devices participants were advised to follow the online instructions. The intervention group 
was informed at the baseline appointment that if any problems occurred throughout the study 
period after the initial set-up regarding the technology they were instructed to contact 
Imperative Health rather than the researcher. This current study wanted to evaluate this WBP 
in a real life setting in order to determine realistic levels of engagement and their relationship 
with weight loss, therefore, no instructions were provided by the researcher as to how often 
the participants should login to use the website components and the self-monitoring devices. 
The WBP, however, does itself encourage daily engagement by allowing the upload of daily 
weight and physical activity data and by the entry of daily food diaries (see below for more 
detail).  
  
Web-based behaviour change program   
  
Once the online account was set up the participants were required to complete a series of 
online introductory health questionnaires that enabled Imperative Health to collect 
information on their height, weight, waist circumference, blood pressure and blood 
biomarkers (total cholesterol, HDL cholesterol, fasting blood glucose and triglycerides), as 
well as information on past and current health status, dietary intake, physical activity level 
and stated goals. This self-reported information was not used by the researcher to evaluate the 
effects of this WBP; instead, it was used by the Imperative Health system to generate 
personalised daily targets (weight loss, physical activity and dietary targets) for each 
participant to achieve over 12 weeks. Automated weekly feedback on their performance, 
assessed by the self-monitoring devices (weighing scales and accelerometer), as well as the 
food diary was provided and also after 12 weeks in the form of an overall review. After 12 
weeks, in order to encourage further progress, it was requested that the participants start a 
new program by completing the same introductory health questionnaires again and setting 
new goals. The WBP encompasses supportive components to help facilitate lifestyle change 
(See Table 1). These WBP components were developed based on well recognised behaviour 
change strategies such as: planning, self-monitoring, goal setting and structured feedback, 
which were all used within the Diabetes Prevention Program [20] to promote weight loss.  
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Table 1 Imperative Health WBP components to support behaviour change  
Behaviour 
Change 
strategy 
WBP component Description of component 
 
Goal setting 
 
- Daily dietary targets 
- Daily physical 
activity targets 
- Weekly weight loss 
targets 
- Clinical targets 
 
Personalised daily dietary, physical activity (see 
Multimedia Appendix 2), weight and clinical (blood 
pressure/ glucose/ lipids) targets were created based 
on the health questionnaire responses (see above). 
Targets were reviewed every 12 weeks. 
 
Planning 
 
Exercise weekly 
schedule 
 
A weekly schedule for planning physical activity 
was provided. Icons (representing light, moderate or 
vigorous activities) could be dragged to specific 
days. Start times and duration of the activity could 
be selected (see Multimedia Appendix 2).  
 Daily meal planners Meal suggestions for breakfast, lunch, dinner and 
snacks were provided to help meet personalised 
dietary targets set by the WBP. 
 
Self-
monitoring 
 
- Bluetooth weighing 
scales 
- Bluetooth 
accelerometer 
activity band 
- Food diary (calorie 
uploads) 
- Clinical 
measurements (blood 
pressure, glucose, 
blood lipids uploads). 
 
Monitoring devices included Bluetooth enabled 
weighing scales and an activity band. Data from the 
weighing scales was transmitted to the activity band 
and subsequently blue toothed to the user’s online 
profile page. The activity band provided daily 
feedback on minutes of moderate, high and very 
high activity (see Multimedia Appendix 3). 
Daily calorie intake, blood pressure, glucose and 
blood lipid measurements could be entered and 
uploaded onto coloured charts (see Multimedia 
Appendix 3 and 4) to demonstrate daily, weekly 
and monthly results and if targets were achieved. 
 
Personalised 
feedback 
 
Coaching session – 
automated weekly 
feedback 
 
Automated tailored feedback on progress was 
provided weekly. 
 
Push 
reminders 
 
Email/ SMS texts 
 
Text messages or emails were sent daily and weekly 
to help remind participants to login and to weigh 
themselves. 
 
Social 
support 
 
Community forum 
 
Online discussion forums.  
 
The 
Decision 
balance 
 
Habit breaker 
component  
 
Solutions for barriers perceived as preventing 
healthier behaviours (e.g. eating breakfast) being 
adopted were provided. 
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Theory 
Outcome measures 
 
Assessments were carried out face-to-face at the Regional Centre for Endocrinology and 
Diabetes at the Royal Victoria Hospital Belfast at baseline, 3 months, 6 months and 12 
months.  
 
Primary outcome 
 
The primary outcome for this study was between-group change in body weight (kg) at 3 
months. Weight was measured, without shoes and in light clothing, to the nearest 0.1 kg using 
calibrated Salter 994 digital weighing scales (Salter Housewares Ltd, Tonbridge, UK). 
 
Secondary outcomes  
 
Secondary outcomes were between-group change in weight loss at 6 and 12 months and 
between-group change in the following risk markers at each follow-up: Body mass index 
(BMI) calculated as weight (kg) divided by height (m) squared; height was measured to the 
nearest 0.1 cm using a Leicester portable height measure (CMS Weighing equipment Ltd, 
London, UK); waist circumference was measured to the nearest 0.5 cm using a tape measure 
at the middle point between the lower rib margin and iliac crest at normal expiration.  
 
Blood pressure (mmHg) was measured using an automated Omron M3 sphygmomanometer 
(Omron Healthcare, Hoofddorp, The Netherlands). 
 
Fasting serum lipid profile included measurements of total cholesterol, high density 
lipoprotein (HDL) cholesterol and triglycerides and were measured using standard assays on 
an automated ILab 600 Chemistry system (Instrumentation Laboratory, Cheshire, UK). 
Plasma hs-CRP (CRP) was measured using an ultra-sensitive assay (quantex CRP ultra-
sensitive; Instrumentation Laboratory, Cheshire, UK) on an automated machine, (ILab 600 
Chemistry System). 
 
Dietary intake was assessed using a diet history interview [21], which is a retrospective 
dietary assessment method used to gather information regarding the habitual food intake of all 
the participants over the previous 3 months. The diet history method has been shown to have 
good repeatability in previous studies and is also able to pick up dietary changes over time 
[22]. Quantities of food and food portion sizes (household measures) were converted into 
weights (grams) by using Crawley’s Food Portion Sizes (Food Standards Agency) [23]. The 
food type, preparation method if relevant, and weight of food were entered into a 
computerised food analysis database (WISP, Weighed Intake Software Program; Tinuviel 
Software, Warrington, UK). For the purpose of this current study total daily energy intake 
(kcal) was calculated. 
 
Physical activity was assessed using the validated Recent Physical Activity Questionnaire 
(RPAQ) [24]. Participants were asked to provide descriptions of their habitual physical 
activity performed in four domains: home, work, travel and recreation over the last four 
weeks. For the purpose of this current study time (min/day) spent participating in moderate 
and vigorous activities (> 3.5 METs) was calculated. 
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A self-reported questionnaire was distributed at the baseline appointment to collect socio-
demographic information including past and current occupation. Socioeconomic status was 
classified according to National Statistics Socio-economic Classification (NE-SEC, 
Hampshire, UK, 2010) into three occupational classes: the highest included higher 
managerial, administrative and professional occupations; the second class was intermediate 
occupations; and the third class included routine and manual occupations. 
Website usage 
 
Data on frequency of logins, the total number of completed food diaries and the number of 
weight and physical activity uploads from the monitoring devices were provided by 
Imperative Health and were used to determine level of engagement. 
 
Qualitative – Interviews 
 
To gain in-depth feedback on the intervention group’s experiences of using the WBP these 
participants were asked if they would be willing to take part in an interview conducted by the 
researcher towards the end of the study. This was an optional part of the study and for this 
reason a convenience sampling technique was utilised. The interviews were conducted 
between July and August 2012, in the Centre for Public Health, QUB, within an informal 
setting and lasted ∼25–30 minutes. Semi-structured open-ended questions were used 
throughout to ensure that a consistent approach was utilised. The researcher used a style of 
probing to extract more information or clarify meaning.   
All the interviews were audio-recorded and transcribed verbatim. NVivo 8 was used to assist 
in the management and analysis of the transcripts. To analyse the transcripts a template 
approach, outlined by Cabtree and Miller [25] was utilised. This process involved the naming, 
defining and describing of the codes based on research questions. Three broad categories 
formed the code template: views on their experiences of using Imperative Health (WBP), 
views on Imperative Health’s website components that support behaviour change and 
suggested improvements that Imperative Health should implement. The template of codes 
was then applied to all transcripts. Given that the data were qualitative, frequencies were used 
in the broadest sense (e.g. majority, some and few). Quotations were used to demonstrate 
typical views within each code category.  
 
Statistical Analysis 
 
All analyses were performed using SPSS for Windows version 21.0 (SPSS Inc, Chicago, IL). 
Results are expressed as mean and standard deviation for normally distributed variables and 
median and inter-quartile range for variables that did not satisfy normality criteria. 
Categorical data are expressed as frequencies and percentages. To compare baseline 
characteristics between the control and intervention groups, for continuous variables, the 
appropriate parametric (Independent samples t-test) and non-parametric tests (Mann Whitney 
U test) were utilised. For categorical variables the Chi-square test was used. Between-group 
differences in the primary outcome (weight change at 3 months) and secondary outcomes 
from baseline to 3 months, 6 months and 12 months were investigated using the analysis of 
covariance (ANCOVA) adjusted for baseline measurements [26]. Analyses were carried out 
by an intention-to-treat (ITT) approach using a single imputation method (baseline 
observation carried forward, BOCF) to deal with missing data and losses to follow-up [27], 
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and a complete-case analysis on weight change was conducted using information on all 
individuals with available data at each time point. C-reactive protein, triglycerides and 
physical activity distributions were skewed and therefore log transformed. Adjusted 
differences in log-transformed means between groups from ANCOVA were converted to, and 
reported as, ratios of geometric means and 95% confidence intervals. Within-group changes 
(intervention or control) in weight loss were analysed using paired sample t-test. As the WBP 
usage data was not normally distributed, Spearman correlations were performed to investigate 
the relationship between weight change and WBP usage at each time point (intervention 
group only).  
 
Results  
 
Participant Flow 
 
Eighty-one individuals were screened for eligibility. Sixteen were ineligible; the other 65 
participants (29 males, 34 females) were randomised to the control (n=33) or intervention 
(n=32) groups (see Figure 1). Retention rates significantly differed between the control and 
intervention groups at 3 months (n=32 (97%) vs. n=25 (78%), P=.03), at 6 months (n=31 
(94%) vs. n=21 (66%), P=.004) and at 12 months (n=29 (88%) vs. n=17 (53%), P=.002), 
respectively. Baseline characteristics, including socio-economic status, did not differ 
significantly between those who dropped-out of the study and those who completed the study 
in either group at any time point.  
 
Baseline characteristics  
 
Mean age was 52.1 ± 7.4 years and mean BMI at baseline was 32.7 kg/m
2
. According to 
WHO criteria [28], 20% of the sample were overweight, 58.5% were obese category I and 
21.5% were obese category II. Socio-economic status (SES) was determined by occupational 
class (NS-SEC):  Class 1 included higher managerial, administrative and professional 
occupations which approximately half the sample (50.3%) lay within; Class 2 included 
intermediate occupations of which 38.5 % of the sample lay within; and Class 3 included 
routine and manual occupations, and applied to 10.8% of the sample.  There were no 
significant differences in any of the baseline characteristics between the control and 
intervention group (Table 2). 
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Table 2 Baseline characteristics of overweight and obese participants, according to control 
and intervention group   
 Intervention (n = 32) Control  (n = 33)  
 Mean (SD) Mean (SD) P value 
    
Gender, male n(%) 16 (50) 13 (39)  
             female n(%) 16 (50) 20 (61) .39 
Age (years) 51.4 (7.59) 52.9 (7.27) .43 
Weight (kg) 95.2 (16.7) 91.9 (13.4) .39 
Height (cm) 169.4 (9.44) 168.1 (9.35) .57 
BMI (kg/m
2
) 32.9 (3.07) 32.4 (2.74) .50 
Waist circumference (cm) 103.5 (11.2) 102.5 (9.47) .69 
Systolic Blood pressure (mmHg) 129.8 (17.8) 129.1 (18.3) .88 
Diastolic Blood pressure (mmHg) 85.5 (9.54) 86.0 (11.4) .85 
Total cholesterol (mmol/l) 4.87 (1.44) 5.16 (1.02) .35 
HDL (mmol/l) 1.33 (0.39) 1.36 (0.31) .77 
Triglycerides
1
 (mmol/l) 1.49 (1.18-1.86) 1.48 (1.01-2.02) .75 
CRP
1
 (mg/l) 1.73 (0.67-2.90) 2.11 (1.11-4.35) .22 
Energy (kcal) 1949.6 (545.1) 1893.6 (477.2) .66 
Physical Activity
1
 (mins/day) 15.5 (6.4-45.3) 17.40 (7.5-46.9) .72 
Continuous data presented as mean (SD) for normally distributed data and 1median (IQ) for skewed data. Between-group differences 
analysed using independent samples t-test for normal data and Mann Whitney test for skewed data. Categorical data presented as frequencies 
(%). Differences between categories analysed using Chi-squared test (X2 test) Abbreviations: BMI, body mass index; HDL, high-density 
lipoprotein cholesterol; CRP, C-reactive protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 CONSORT diagram showing the flow of participants through the trial and analysed 
for weight loss at 3 months, 6 months and 12 months 
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Lost to follow-up at 12 month (n=2)  
Personal Illness (n=1) 
Unknown (n=1) 
 
 
 
 
Lost to follow-up at 12 month (n=4) 
Family illness (n=2) 
Time constraints (n=1) 
Unknown (n=1) 
 
 
 
 
Lost to follow-up at 6 month (n=4)  
Personal reasons (n=3) 
Unknown (n=1) 
 
 
 
 
 
Lost to follow-up at 6 month (n=1) 
Personal reasons (n=1) 
 
 
 
 
 
Assessed for eligibility  
(n=81) 
 
 
Excluded (n=16) 
N=15 – Did not have one or more of 
the pre-specified CVD risk factors 
N=1 – BMI over 40 
 
 
 
Lost to follow-up at 3 months (n=7) 
Technology issues (n=2) 
Time constraints (n=3) 
Family illness (n=2) 
 
 
 
 
Lost to follow-up at 3 months (n=1) 
Time constraints (n=1) 
 
 
 
 
 
Allocated to control (n=33) 
Received allocated control (n=33) 
 
 
 
Allocated to Intervention (n=32)  
Received allocated intervention (n=32) 
 
 
Randomised 
(n=65) 
 
Allocation 
 
3 month 
follow-up 
 
6 month 
follow-up 
 
12 month 
follow-up 
 
Analysis 
 
ITT analysis carried out 
 : 
Completers at: 
3 months (n=25) 
6 months (n=21) 
12 months (n=17) 
 
 
 
 
ITT analysis carried out 
 Completers at: 
3 months (n=32) 
6 months (n=31) 
12 months (n=29) 
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Change in body weight (primary outcome) 
 
As shown in Table 3, both approaches (ITT and complete-case) demonstrated significant mean 
weight loss difference between groups at 3 months; however the magnitude of weight lost was 
slightly higher using the complete-case analysis approach. ITT analysis revealed that the 
Intervention group participants had a mean weight loss of -3.41 kg at 3 months; the control 
group lost -0.52 kg, overall this accounted for a significant mean weight difference between 
groups of -2.70 kg after adjusting for baseline weight (P <.001). 
Table 3 Weight (kg) outcome differences between and within study groups from baseline to 3, 
6 and 12 months (ITT and complete-case analysis) 
  Change from baseline  Difference between  Between-  
  Mean (95% CI) groups group 
 Month Intervention Control Mean (95% CI) P value 
      
ITT 3 -3.41 (-4.70, -2.13)
c
 -0.52 (-1.55, 0.52) -2.70 (-4.27, -1.13) .001 
 6 -3.47 (-4.95, -1.98)
c
 -0.81 (-2.23, 0.61) -2.49 (-4.50, -0.48) .02 
 12 -2.38 (-3.48, -0.97)
b
 -1.80 (-3.15, -0.44)
a
 -0.27 (-2.16, 1.61) .77 
Complete- 3 -4.37 (-5.80, -2.94)
c
 -0.53 (-1.60, 0.54) -3.66 (-5.28, -2.05) < .001 
case 6 -5.28 (-7.12, -3.44)
c
 -0.86 (-2.38, 0.65) -4.16 (-6.46, –1.86) .001 
 12 -4.48 (-7.34, -2.37)
b
 -2.16 (-4.58, -0.62)
a
 -1.89 (-4.42, 0.64) .14 
Difference between groups analysed using ANCOVA and adjusted for baseline weight. Abbreviations: ITT, intention to treat. ITT analysis: 
control group (n=33) and intervention group (n=32) at 3, 6 and 12 months. For the complete-case analysis: control group (n=32) at 3 months, 
(n=30) at 6 months and (n=29) at 12 months. Intervention group (n= 25) at 3 months, (n=21) at 6 months and (n=17) at 12 months.  Within-
group weight changes were analysed using paired sample t-test and only significant results are presented aP ≤ 0.05, bP ≤ 0.01, cP ≤ 0.001 
 
Change in body weight at 6 and 12 months (Secondary outcome) 
 
Intention-to-treat analysis (Table 3) demonstrated that the intervention group lost significantly 
more weight compared to the control group from baseline to 6 months (-3.47 kg vs. -0.81 kg; 
P=.02, respectively) but not from baseline to 12 months (-2.38 kg vs. -1.80; P=.77). There were 
significant changes in weight between baseline and each time point within the intervention 
group (3 months, P <.001; 6 months, P <.001 and 12 months, P=.002). However, between 6 
months and 12 months the intervention group gained 1.08 kg, reducing the overall mean 
weight loss at 12 months in this group. There was a significant weight loss from baseline to 12 
months within the control group (-1.80 kg; P=.01) but not for the 3 month (P=.32) and 6 month 
(P=.25) time points. 
 
Percentage weight loss 
 
Weight loss as a percentage of baseline weight was calculated using the ITT data. The mean 
percentage weight loss in the intervention and the control group was: from baseline to 3 
months -3.62% vs. -0.34%, respectively (P <.001); from baseline to 6 months -3.73% vs. -
0.63% respectively (P=.004); and from baseline to 12 months -2.42% vs. -1.94%, respectively 
(P=.56). Significantly more participants in the intervention group compared with the control 
group lost 5% or more of their baseline body weight at 3 months (34.4% vs. 3.0%, P <.001) 
and at 6 months (40.6% vs. 18.2%, P=.047), but not at 12 months (21.9% vs. 21.2%, P=.95).  
 
Change in other Secondary Outcomes 
 
Table 4 shows the intervention group had significantly reduced their BMI and waist 
circumference measurements relative to the control group from baseline to 3 months (P <.001 
and P=.006, respectively) and to 6 months (P=.003 and P=.02, respectively), but not at 12 
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months. There were no between-group differences in blood pressure observed during the study. 
For lipid measurements, larger reductions were observed in total cholesterol and triglyceride 
concentrations in the intervention group compared to the control group, but only during the 
first 3 months (P=.003 and P=.003; respectively). Similar patterns were identified for health 
behaviours: the intervention group significantly decreased their energy intake and increased 
their time spent exercising at an intensity > 3.5 METs relative to the control group from 
baseline to 3 months (P=.005 and P=.03). These behaviours were not sustained over the longer 
term, at 6 and 12 months. 
 
Table 4 Clinical outcome differences between study groups from baseline to 3, 6 and 12 
months (ITT) 
Data presented as mean and 95% CI for normal distributed variables and 1ratios of geometric mean and 95% confidence for log transformed 
variables. 2Difference between groups analysed using ANCOVA and adjusted for baseline measurements. Abbreviations: BMI, body mass 
index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL, high density 
lipoprotein cholesterol; TG, triglycerides; CRP, C - reactive protein. Physical activity calculated as time in minutes spent exercising >3.5 
METS daily. 
 
 
 
  Treatment Groups   
  Mean change from baseline (95% CI) Between-group difference  
 Month Intervention (n=32) Control (n=33) Adjusted mean (95% CI)
2 
P  
      
BMI  3 -1.16 (-1.60, -0.73) -0.14 (-0.47, 0.19) -0.99 (-1.53, -0.46) <.001 
(kg/m
2
) 6 -1.20 (-1.70, -0.70) -0.18 (-0.64, 0.27) -1.02 (-1.69, -0.35) .003 
 12 -0.78 (-1.26, -0.31) -0.65 (-1.12, 0.19) -0.10 (-0.75, 0.55) .76 
WC 3 -2.73 (-3.98, -1.49) -0.67 (-1.44, 0.11) -2.04 (-3.47, -0.61) .006 
(cm) 6 -3.05 (-4.68, -1.41) -0.83 (-1.95, 0.28) -2.18 (-4.11, -0.24) .02 
 12 -2.31 (-3.84, -0.79) -1.80 (-3.02, -0.58) -0.42 (-2.29, 1.45) .66 
SBP 3 -2.69 (-6.48, 1.10) -1.64 (-6.02, 2.75) -0.81 (-5.61, 3.99) .74 
(mmHg) 6 -1.31 (-4.83, 2.20) 0.88 (-3.79, 5.55) -1.92 (-6.48, 2.65) .40 
 12 -1.22 (-4.33, 1.90) -2.12 (-2.25, 6.49) -3.13 (-7.69, 1.43) .18 
DPB 3 -3.03 (-5.14, -0.92) -2.36 (-5.02, 0.29) -0.83 (-3.76, 2.10) .58 
(mmHg) 6 -2.63 (-5.05, -0.20) -1.73 (-5.26, 1.81) -1.14 (-4.55, 2.27) .51 
 12 -1.78 (-3.52, -0.05) -1.55 (-4.57, 1.48) -0.38 (-3.52, 2.76) .81 
TC 3 -0.49 (-0.70, -0.28) -0.06 (-0.31, 0.19) -0.48 (-0.79, -0.18) .003 
(mmol/l) 6 -0.30 (-0.53, -0.08) -0.24 (-0.46, -0.02) -0.07 (-0.38, 0.24) .64 
 12 -0.19 (-0.38, -0.01) -0.13 (-0.36, 0.10) -0.09 (-0.38, 0.20) .56 
HDL  3 -0.02 (-0.08, 0.04) 0.00 (-0.07, 0.07) -0.03 (-0.11, 0.06) .51 
(mmol/l) 6 -0.01 (-0.07, 0.06) -0.03 (-0.10, 0.04) 0.02 (-0.07, 0.12) .62 
 12 -0.02 (-0.07, 0.02) 0.02 (-0.06, 0.10) -0.04 (-0.13, 0.04) .32 
TG
1
  3 0.89 (0.82, 0.96) 1.03 (0.96, 1.10) 0.87 (0.80, 0.95) .003 
(mmol/l) 6 0.96 (0.89, 1.04) 0.98 (0.91, 1.04) 0.99 (0.90, 1.09) .79 
 12 0.97 (0.91, 1.02) 0.97 (0.90, 1.05) 1.00 (0.92, 1.09) .93 
CRP 
 3 0.93 (0.84, 1.03) 1.01 (0.87, 1.18) 0.88 (0.74, 0.96) .13 
( mg/l)
1
 6 0.89 (0.83, 0.95) 1.03 (0.86, 1.24) 0.83 (0.69, 1.01) .06 
 12 0.99 (0.80, 1.23) 0.99 (0.81, 1.21) 0.93 (0.71, 1.21) .58 
Energy 3 -487.6 (-640.7, -334.5) -241.4 (-375.8, -106.9) -216.3 (-364.0, -68.7) .005 
Intake  6 -314.8 (-466.2, -163.5) -243.2 (-393.6, -92.8) -47.8 (-228.5, 133.0) .60 
(Kcal) 12 -221.6 (-363.5, -79.8) -204.2 (-384.5, 23.9) 7.20 (-191.0, 205.4) .94 
Physical 
 3 2.85 (1.64, 4.94) 1.43 (0.92, 2.21) 1.98 (1.09, 3.60) .03 
Activity
1
 6 1.43 (1.00, 2.06) 1.00 (0.61, 1.64) 1.43 (0.84, 2.44) .19 
(min/day) 12 1.52 (0.95, 2.43) 1.18 (0.74, 1.89) 1.28 (0.72, 2.27) .40 
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Website usage and weight change (Intervention group only) 
 
Website utilisation data is presented in Table 5. Participants in the intervention group tended to 
login, upload their weight measurement and make food diary entries more frequently during 
the first 3 months of the intervention, website usage declined thereafter.  
 
Table 5 Website utilisation from baseline to 3, 6 and 12 months (intervention group only) 
Data presented as median (IQ) due to data being skewed. Sample size at 3 months (n=25), at 6 months (n=21) and at 12 months (n=17). 
 
Correlation analyses (Table 6) demonstrated that weight change from baseline to the 3 month 
follow-up was significantly positively related to the number of logins (P=.04) and the number 
of weight uploads (P=.007) at 3 months. A positive relationship was observed between weight 
change from baseline to 6 months and the amount of physical activity uploads over the same 
time period (P=.048). The number of daily food diaries entered was not related to weight 
change throughout the course of the study. 
 
Table 6 Correlations between weight change and website components usage from baseline 
(intervention group only) 
 Weight change from baseline 
Website component usage 3 months (r) P value  6 months (r) P value 12 months (r) P value 
       
Number of logins 0.42 .04 0.28 .21 0.21 .42 
Food diary entries 0.01 .96 0.00 .99 -0.20 .53 
Physical activity uploads 0.33 .14 0.47 .048 0.12 .67 
Weight uploads 0.53 .007 0.20 .39 0.10 .70 
Data analysed by Spearman’s correlation. 
 
Interview feedback (intervention group only)  
 
A total of seven participants (four males and three females) from the intervention group were 
recruited using a convenience sampling approach. Three broad categories formed the code 
template: views on their experiences of using Imperative Health (WBP), views on Imperative 
Health’s website components (see Table 1) that support behaviour change and suggested 
improvements that Imperative Health should implement. Below are some of the quotations 
used to demonstrate typical views within each code category. 
 
Experiences using Imperative Health (WBP) 
 
All of the interviewees stated that they were keen to use this WBP to help them lose weight 
and manage their chronic condition. They found the initial set up of their Imperative Health 
accounts relatively straightforward.   
 Baseline to 3 months 3 to 6 months 6 to 12months 
 (13 weeks) (13 weeks) (26 weeks) 
 Median (IQ) Median (IQ) Median (IQ) 
    
Number of logins 69.0 (25.5 – 122.0) 12.0 (2.00 – 47.5) 27.0  (2.00 – 96.8) 
Food diary entries  18.0 (0.00 – 77.0) 0.00 (0.00 – 38.5) 0.00 (0.00 – 156.5) 
Weight uploads  15.0 (9.0 – 46.0) 11.0 (1.0 – 30.0) 4.0 (0.0 – 29.8) 
Physical activity uploads  13.0 (10.0 – 13.0) 12.0 (3.0 – 13.0) 15.0 (0.00 – 24.5) 
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“It was very straightforward. I don’t think I had any difficulty at all with it.”  
Some of the interviewees perceived using the WBP as time consuming and quite burdensome, 
specifically, the tasks that involved uploading and manually entering measurements as well as 
working through the weekly feedback. 
“I don’t know whether people who would be employed full time would have enough time to do 
that ... If you’re running out to work in the morning and you have to be out for 7 o’clock, 
you’re not going to be standing there weighing yourself, and again, when you come back home 
again, typing in what you have done”  
 
And 
 
“If you wanted a quick consult it was taking you 10 minutes to get through ...” 
 
Website components that support behaviour change 
 
The majority of interviewees found the personalised targets (weight loss, physical activity and 
dietary targets) provided by the WBP as realistic and motivating. 
 
“It did give me the motivation to say ‘right, I’m supposed to go walking 60 minutes a day. I’ll 
try and keep to that target of 60 minutes a day’. 
 
And  
 
“They weren’t tough; the calories I was being allowed were okay...” 
 
The majority of interviewees were not impressed with the WBP planning components (meal 
planner and exercise schedule). Accessibility issues and aversions to the recommended foods 
in the meal plans were commented. 
 
“If it had of been pre-packaged food or something that I would have actually liked but there 
was none of the stuff that really appealed to me. So I never used the meal planner...” 
 
And 
 
“But they were all foods that were for supermarkets, say, in England and a lot of the stuff that 
you wouldn’t get here maybe.” 
  
All the interviewees felt that the WBP’s self-monitoring components (weighing scales and 
accelerometer activity band – data from these devices were uploaded onto coloured charts to 
track progress) helped them to evaluate their progress and at the same time acted as facilitators 
for motivating them to keep continuing towards their targets.   
 
“With regard to the weight one, it encouraged you to do better, because it showed if you were 
flattening out or, at worst, going the wrong way off your target.” 
 
And 
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“I found the activity useful because when I would sync up at the end of the week I would have 
a look and say ‘I was low on Tuesday and Wednesday this week. I’ll maybe do a boost on 
Friday. I’ll go for an hour and a half walk just to make sure my average for the week is up’. So 
I found that a little bit, slightly motivating.” 
 
All of the interviewees provided negative feedback regarding the dietary self-monitoring 
element of this WBP (food diary). They felt the process was time consuming and burdensome 
as a result of having to look up all the calories of the foods they consumed and then enter them 
manually into the food diary.  
 
“I found getting the nutritional values of things awkward because you had to go into a separate 
wee thing in the background and then you had to write it down and then you go back to 
something else.”  
 
Most of the interviewees claimed they did not use the component for monitoring their clinical 
measurements, as they were unable to get these health risk factors measured regularly. 
 
“... the average person doesn’t have that information.  I might get that done twice a year.” 
 
The majority of the participants were not impressed with the automated feedback and coaching 
sessions provided weekly. They felt that it was too generic and repetitive; hence not 
encouraging or constructive.   
 
“The other thing that irritated me intensely is the standard messages that you would get at 
every stage of the bloody feedback! I suppose it’s a computer system, what can you expect, but 
I just got cheesed off because it said the same thing all the time.” 
 
And  
 
“It was more generic in the sense. They were just basically saying ‘we haven’t got enough 
information’ or ‘you have not met your target.’ 
 
Most participants stated that they did browse the community forum but did not contribute 
anything. They generally felt that there was not enough activity. 
 
“I occasionally dipped in and out to see what it was but there was very little action or interest, 
and I don’t get involved in anything like that at all.” 
 
Suggested improvements  
 
A common suggestion for improvement was more personalised interaction and feedback 
specifically from a human rather than an automated machine as this may provide them with 
more focus and motivation. This would be in line with the full Imperative Health service that 
has physiologists supporting participants by telephone and email. 
 
“... some more personalised interaction in terms of somebody perhaps phoning you on your 
mobile to give you a kick start or perhaps an email...”  
 
And 
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“I tried at the start, and because there is not actually a person involved in it you’re not worried 
about what the machine tells you then, you don’t care what it says to you.  So you go off track 
a wee bit...”  
 
Discussion 
 
Weight loss (primary and secondary outcome) 
 
In comparison to a ‘true control’ group, access to a WBP resulted in significantly greater 
weight loss in the intervention group after 3 and 6 months. However, longer-term follow-up 
indicated that the difference in weight loss between the intervention and control group was not 
sustained at 12 months. The reasons for this were twofold: weight regain in the intervention 
group between the 6 and 12 month time point and an increase in weight loss in the control 
group over the same time period. In terms of clinically significant weight loss (weight loss of ≥ 
5% of baseline body weight), significantly more participants in the intervention group 
compared with the control group lost 5% or more of their baseline body weight at 3 months 
(34.4% vs. 3.0%, P <.001) and at 6 months (40.6% vs. 18.2%, P=.047), but not at 12 months 
(21.9% vs. 21.2%, P=.95). 
  
Engagement, non-usage attrition and attrition 
 
This study was designed to evaluate this WBP in a real life setting in order to observe real 
levels of engagement and their relationship with weight loss; hence, no instructions were given 
to participants regarding how often they should login to use the website and the self-
monitoring devices. The Imperative Health program does itself encourage daily engagement by 
allowing the upload of daily weight and physical activity data, captured by the accelerometer 
activity band and by the entry of daily food diaries. Some studies have suggested that an 
unstructured ‘self-care’ approach may limit the potential benefit of internet programs [29,30], 
however, prescriptive dosage studies are likely to represent efficacy rather than effectiveness 
and do not help to understand the likely true public health impact of these novel modes of 
delivery. Studies that have provided dosage instructions have found positive effects. For 
example, participants that comply with the dosage instructions tend to lose significantly more 
weight than non-compliers [14,31,32,33]. The majority of these prescriptive dose studies, 
however, were conducted over the short term (6 months or less). Sustaining engagement levels 
in the long term is undoubtedly more of a challenge. Weight change (3 months) in this current 
study had a positive moderate correlation with the number of logins and weight uploads but 
engagement levels tended to diminish with time, particularly after 6 months. Web-based 
programs in general tend to have problems with long-term sustainability and non-usage 
attrition tends to be a common characteristic that increases steadily over time [2,30]. 
Participants are likely to disengage over time, perhaps due to motivational issues and, 
particularly, if they are failing to lose weight or have reached a plateau [34]. Furthermore, 
depending on the WBP itself and what it has to offer in terms of interactivity and level of 
intensity, participants may simply get bored and lose interest in the WBP.  
 
Attrition rates are generally high in web-based weight loss studies and have been reported to 
range between 0 and 70%, with a mean attrition rate of 22.5% [7]. Furthermore, attrition rates 
have been reported to be higher within the web-based intervention group [29,31,35,36,37] 
relative to the control group, as was the case in this current study.  
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Interactivity is essential for high engagement and low attrition, furthermore, it is well accepted 
that WBPs with enhanced interactive features promote greater weight reductions than those 
that provide information only [5]. The WBP described in this current study encompassed an 
interactive design by encouraging self-monitoring and providing automated feedback yet high 
levels of attrition and long-term disengagement levels were evident. Incorporation of more 
individualised personal support rather than automated feedback may have helped engagement 
levels, particularly at the 6 month juncture.  The majority of participants who took part in an 
interview suggested that the addition of more personalised interaction, by a phone call or email, 
rather than an automated machine providing standard feedback would be more motivating and 
help preserve their interest to keep using the program. Similar studies evaluating the effect of 
WBPs on weight loss have reported higher effect sizes and usage when face-to-face contact is 
incorporated into the intervention [4]. This would be in line with the complete Imperative 
Health service; however, it was important to assess the WBP on its own in order to understand 
its specific contribution.  
 
Incorporation of WBPs into traditional care pathways for weight loss has generally taken the 
approach of comparing standard healthcare with standard healthcare plus WBP over a defined 
period of time. An alternative model of care that may be worth further investigation is to use 
WBPs for initiation of weight loss and then add in further interventions, rather than using 
WBPs alongside other interventions from the outset. Addition of more interpersonal 
interventions, at the later stage would perhaps encourage sustained behaviour change, prevent 
attrition from the 6 month time point onwards and support the weight loss maintenance stage. 
Such a model has particular relevance for healthcare systems, for example, waiting lists to be 
seen by Dieticians in the UK National Health Service can be many weeks; referral to use a 
WBP during this time would be a useful way of initiating weight loss and may be particularly 
appealing for patients who do not feel comfortable attending weight loss groups.  
 
Secondary outcomes 
 
In terms of cardiovascular risk, between-group analyses demonstrated that the intervention 
group significantly improved their BMI and waist circumference at 3 months and 6 months and 
their total cholesterol and triglycerides from baseline to 3 months in comparison with the 
control group, however, these significant between-group changes were not sustained at 12 
months. The WBP did provide a self-monitoring tool for tracking blood pressure, lipids and 
lipoprotein levels but intervention group participants did not avail of this part of the program. 
When this was discussed at the interview sessions, the majority of participants stated that the 
main reason they didn’t access this part of the program was that they weren’t able to have these 
risk factors measured regularly. This is a general disadvantage of WBPs that do encourage the 
monitoring of other health risk factors but don’t provide the means to conduct the 
measurements at the participant’s own convenience.  
It was evident that the intervention group adopted healthier behaviours specifically in the short 
term. The significant increase in time spent exercising moderately and above (> 3.5 METs) and 
the decrease in energy intake observed in the intervention group in comparison with the control 
group was likely to be attributable to the self-monitoring components of the web-based 
program. Usages of these self-monitoring features were also correlated with short-term weight 
change (baseline to 3 and 6 months). Physical activity levels were not sustained in the longer 
term and the number of weekly physical activity uploads notably decreased between 6 and 12 
months. These findings are consistent with those already reported in the literature [38,39]. A 
systematic review examining the effects of self-monitoring diet, physical activity and weight 
on weight loss [38] found a consistent and positive significant association between the 
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frequency of the self-monitoring behaviours and weight loss compared to less frequent self-
monitoring. It was also reported in this review that a gradual decline over time in adherence to 
self-monitoring weight management behaviours is common [38].  
 
Strengths and limitations 
 
The strengths of this study included its robust study design, the objectively measured primary 
outcome and the mixed method research approaches (qualitative and quantitative) used 
throughout the evaluation process. Furthermore this study included a ‘true control group’; the 
majority of studies in this area tend to use a minimal support group in order to boost 
recruitment and decrease attrition, however, this may attenuate the relationship between 
groups. This study was conducted within a real life setting and participants were not provided 
with strict instructions as to how often they should use the program, therefore making the 
results more generalisable to overweight populations accessing these WBPs at home for their 
own self-care.   
 
This study did have some limitations, for example, all participants had contact with the 
researcher during clinical assessments, and knew this was a weight loss study, which in itself 
may have triggered a behaviour change response, and this ‘Hawthorne effect’ [40] appears to 
be evident within the control group. The researcher, however, did not give any advice during 
the assessment period to either group.  
 
Issues of attrition or loss to follow-up and non-usage attrition steadily increased over time, but 
this phenomenon is commonly reported in the literature in relation to weight loss management 
[34] and is not unique to WBPs. From a scientific perspective, attrition and non-usage attrition 
can impact on the likelihood of detecting a difference between groups when evaluating the 
treatments over longer periods of time, from a clinical perspective it highlights the challenge of 
maintaining interest, motivation and weight loss in the medium to long term. Another 
limitation is the fact that the study was powered on weight loss at the three month time point; 
therefore, the sample size may have been too small to detect a significant difference between 
groups for some of the secondary outcomes, particularly at the later follow-up time points.  
 
Owing to the routes of recruitment and the fact that people volunteered themselves for this 
study, the majority of the sample was from a higher social economic background. This could 
have potentially affected levels of engagement and attrition. This, however, is not unique to 
similar studies in the literature (Weinstein and Neville) but does suggest the sample is not 
entirely representative of the general overweight and obese population. This will need to be 
borne in mind when considering the potential wider or larger scale impact of the web-based 
behaviour change intervention.  
 
Conclusion 
 
This study provides evidence that this WBP can be used to initiate clinically relevant weight 
loss of 5% or more and promote improvements in total cholesterol and triglyceride 
concentrations in the short term (3- 6 months) in comparison with usual care. These changes, 
however, were not sustained by the WBP alone in the longer term (up to 12 months) and this 
appeared to correspond with a general decline in usage of the WBP over time. The fact that the 
study was powered on weight loss at the 3 month juncture and the high attrition rates at the 12 
month time point in the intervention group could have also prevented significant differences 
between the groups being identified, specifically at the later time point. Nevertheless, results of 
this study highlights a need to augment WBPs with further interventions after 6 months of 
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usage, for example phone or email or face-to-face support, in order to enhance engagement, 
prevent relapses and encourage maintenance of weight loss in the longer-term. The 
effectiveness and cost-effectiveness of such a model of weight management is worth further 
exploration. 
 
Acknowledgments 
 
Funding source: This study was supported by a PhD studentship provided by the Northern 
Ireland Department for Employment and Learning (DEL). Imperative Health (AXA PPP 
Healthcare Ltd) provided the web-based program and monitoring devices without charge. The 
authors would like to acknowledge the Imperative Health team; specifically, John Crudgington 
and Chris Tomkins, for their contribution, assistance and support throughout this project. As 
well as acknowledge Dr Caroline Mercer for undertaking the serum lipid and CRP analysis. 
We would like to thank all the participating volunteers for giving up their time and for their co-
operation. 
 
Authors’ contributions  
  
MCM, JVW and LJW were all involved in the conception of this piece of research. All authors 
listed (SW, JVW, LJW, SJH, AM, ISY, CRC, KMA and MCM) were involved in designing 
this research. SW with the assistance of AM conducted the research. SW with the guidance and 
assistance of CRC analysed the data. SW wrote the manuscript and all authors were involved 
in reading, revising it critically, editing, and approving the final manuscript. 
Conflicts of Interest 
 
L Ware was involved in developing the nutrition and behaviour change elements of the web-
based program. All other authors listed on the manuscript are distinct from the developers and 
sponsors of the intervention. 
Multimedia Appendix 1 
 
CONSORT-eHealth checklist [9].  
 
Multimedia Appendix 2 
 
Imperative Health screenshots (Meal and activity planners). 
 
Multimedia Appendix 3 
 
Imperative Health screenshots (Activity and calorie feedback charts). 
 
Multimedia Appendix 4 
 
Imperative Health screenshots (Clinical measurement feedback chart). 
 
References 
 
1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov 
S, Abbafati C, Abera SF et al. Global, regional, and national prevalence of overweight and 
obesity in children and adults during 1980-2013: a systematic review for the Global Burden of 
21 
 
Disease Study 2013. Lancet 2014 May. PMID:24880830 http://ac.els-
cdn.com/S0140673614604608/1-s2.0-S0140673614604608-main.pdf?_tid=75c88158-2875-
11e4-8a94-00000aacb35f&acdnat=1408544748_92e6032280191e42ec38e4bdaa82da68. 
Accessed: 2014-08-20. Achieved at:  http://www.webcitation.org/6RyDYL5bo 
2. Griffiths F, Lindenmeyer A, Powell J, Lowe P, Thorogood M. Why are health care 
interventions delivered over the Internet? A systematic review of the published literature. J 
Med Internet Res 2006 Jun;8(2):e10. PMID:16867965 
3. Bennett GG, Glasgow RE. The Delivery of Public Health Interventions via the Internet: 
Actualizing their potential. Annu Rev Public Health 2009;30:273-292. PMID:19296777 
4. Kohl LFM, Crutzen R, de Vries NK. Online prevention aimed at lifestyle behaviours: a 
systematic review of reviews. JMIR 2013 Jul;15(7):e146. PMID:23859884 
5. Neve M, Morgan PJ, Jones PR, Collins CE. Effectiveness of web-based interventions in 
achieving weight loss and weight loss maintenance in overweight and obese adults: a 
systematic review with meta-analysis. Obes Rev 2010 Apr;11(4):306-321. PMID:19754633 
6. Arem H, Irwin M. A review of web-based weight loss interventions in adults. Obes Rev 
2011 May;2(501):e236-e243. PMID:20804523 
7. Manzoni GM, Pagnini F, Corti S, Molinari E, Castelnuovo G. Internet-based behavioral 
interventions for obesity: an updated systematic review. Clin Pract Epidemiol Ment Health 
2011 Mar;4(7):19-28. PMID:21552423 
8. Kodama S, Saito K, Tanaka S, Horikawa C, Fujiwara K, Hirasawa R, Fujiwara K, Hirasawa 
R, Shimano H, Ohashi Y, Yamada N, Sone H. Effect of web-based lifestyle modification on 
weight control: a meta-analysis. Int J Obes 2012 May;36(5):675-685. PMID:21694698 
9. Wieland LS, Falzon L, Sciamanna CN, Trudeau KJ, Brodney S, Schwartz JE, Davidson 
KW. Interactive computer-based interventions for weight loss or weight maintenance in 
overweight or obese people. Cochrane Database of Syst Rev 2012(8):CD007675. PMID: 
22895964 
10. Eysenbach G, CONSORT-EHEALTH Group CONSORT-EHEALTH: improving and 
standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet 
Res 2011;13(4):e126 PMID: 22209829 http://www.jmir.org/2011/4/e126/ 
11. Department of Health. The General Practice Physical Activity Questionnaire. A screening 
tool to assess adult physical activity levels, within primary care. Crown. 2014-08-17. 
http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consu
m_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_112134.pdf. 
Achieved at: http://www.webcitation.org/6RtwwLqKt 
12. Tate D, Wing R, Winett R. Using Internet technology to deliver a behavioral weight loss 
program. JAMA 2001 Mar;285(9):1172-1177. PMID:11231746 
22 
 
13. Tate DF, Jackvony EH, Wing RR. A randomized trial comparing human e-mail counseling, 
computer-automated tailored counseling, and no counseling in an Internet weight loss program. 
Arch Intern Med 2006 Aug;166(15):1620-1625. PMID:16908795 
14. Polzien KM, Jakicic JM, Tate DF, Otto AD. The efficacy of a technology-based system in 
a short-term behavioral weight loss intervention. Obesity 2007 Apr;15(4):825-830 
PMID:17426316 
15. Bennett GG, Herring SJ, Puleo E, Stein EK, Emmons KM, Gillman MW. Web-based 
weight loss in primary care: A randomized controlled trial. Obesity 2010 Feb;18(2):308-313. 
PMID:19296777 
16. Hurling R, Fairley BW, Dias MB. Internet-based exercise intervention systems: Are more 
interactive designs better? Psychol Health 2006 Jan;21(6):757-772. 
doi:10.1080/14768320600603257 
17. Hurling R, Catt M, Boni MD, Fairley BW, Hurst T, Murray P, Richardson A, Sodhi JS. 
Using internet and mobile phone technology to deliver an automated physical activity program: 
Randomized controlled trial. J Med Internet Res 2007 Apr;9(2):e7. PMID:17478409 
18. Ware LJ, Hurling R, Bataveljic O, Fairley BW, Hurst TL, Murray P, Rennie KL, Tomkins 
CE, Finn A, Cobain MR, Pearson DA, Foreyt JP. Rates and determinants of uptake and use of 
an internet physical activity and weight management program in office and manufacturing 
work sites in England: Cohort study. J Med Internet Res 2008 Dec;10(4):e56. PMID:19117828 
19. AXA ICAS Ltd. 2012. Imperative Health. http://www.imperativehealth.com. Archived at: 
http://www.webcitation.org/6RwhzAalk  
20. Wing R. Achieving weight and activity goals among diabetes prevention program lifestyle 
participants - The Diabetes Prevention Program Research Group. Obes Res 2004 
Sep;12(9):1426-1434. PMID:15483207 
21. Burke BS. The dietary history as a tool in research. J AM Diet Assoc 23:1041-1046 
22. Block G. A review of validations of dietary assessment methods. Am J Epidemiol 1982 
Apr;115(4):492-505. PMID:7041631 
23. Crawley H, Mills A, Patel S. Food Standards Agency. Food portion sizes, 3
rd
 edition. 
London: TSO; 2002. ISBN:0112429610  
24. Besson H, Brage S, Jakes RW, Ekelund U, Wareham NJ. Estimating physical activity 
energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Am 
J Clin Nutr 2010 Jan;91(1):106-114. PMID:19889820 
25. Crabtree BF, Miller WL. Using codes and code manuals: A template organizing style of 
interpretation. In: Crabtree BF and Miller WL, editors. Doing Qualitative Research. 2
nd
 edition. 
London: Sage; 1999. p. 163-178. ISBN:0761914986 
26. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up 
measurements. BMJ 2001 Nov;323(7321): 1123-1124. PMID:11701584 
23 
 
27. Ware J. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med 2003 
May;348(21):2136-2137. PMID:12761370 
28. World Health Organisation. Obesity: Preventing and managing the global epidemic. Report 
of a WHO Consultation (WHO Technical Report Series 894). Geneva; 2000. 
http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf?ua=1. Archived at: 
http://www.webcitation.org/6Ru2jCNEe   
29. Womble L, Wadden T, McGuckin B, Sargent S, Rothman R, Krauthamer-Ewing E. A 
randomized controlled trial of a commercial Internet weight loss program. Obes Res 2004 
Jun;12(6):1011-1018. PMID:15229342 
30. McConnon A, Kirk SFL, Cockroft JE, Harvey EL, Greenwood DC, Thomas JD, Ransley 
JK, Bojke L. The Internet for weight control in an obese sample: results of a randomised 
controlled trial. BMC Health Serv Res 2007 Dec;7(206). PMID:18093289 
31. Hunter CM, Peterson AL, Alvarez LM, Poston WC, Brundige AR, Haddock K, Van Brunt 
DL, Foreyt JP. Weight management using the Internet a randomized controlled trial. Am J Prev 
Med 2008 Feb;34(2):119-126. PMID: 18201641 
32. Morgan PJ, Lubans DR, Collins CE, Warren JA, Callister R. The SHED-IT randomized 
controlled trial: Evaluation of an internet-based weight-loss program for men. Obesity 2009 
Nov;17(11):2025-2032. PMID:19343018 
33. Morgan PJ, Lubans DR, Collins CE, Warren JM, Callister R. 12-Month outcomes and 
process evaluation of the SHED-IT RCT: An internet-based weight loss program targeting 
men. Obesity 2011 Jan;19(1):142-151. PMID:20523304 
34. Moroshko I, Brennan L, O'Brien P. Predictors of dropout in weight loss interventions: a 
systematic review of the literature. Obes Rev 2011 Nov;12(11):912-934. PMID:21815990 
35. Carr LJ, Bartee RT, Dorozynski C, Broomfield JF, Smith ML, Smith DT. Internet-
delivered behavior change program increases physical activity and improves cardiometabolic 
disease risk factors in sedentary adults: Results of a randomized controlled trial. Prev Med 
2008 May;46(5):431-438. PMID:18207228 
36. Cussler EC, Teixeira PJ, Going SB, Houtkooper LB, Metcalfe LL, Blew RM, Ricketts JR, 
Lohman J, Stanford VA, Lohman TG. Maintenance of weight loss in overweight middle-aged 
women through the internet. Obesity 2008 May;16(5):1052-1060. PMID:18309301 
37. Collins CE, Morgan PJ, Jones P, Fletcher K, Martin J, Aguiar EJ, Lucas A, Neve MJ, 
Callister R. A 12-week commercial web-based weight-loss program for overweight and obese 
adults: Randomized controlled trial comparing basic versus enhanced features. J Med Internet 
Res 2012 Apr;14(2):e57. PMID:22555246 
38. Burke LE, Wang J, Sevick MA. Self-monitoring in weight loss: A systematic review of the 
literature. J Am Diet Assoc 2011 Jan;111(1):92-102. PMID:21185970 
24 
 
39. Krukowski RA, Harvey-Berino J, Bursac Z, Ashikaga T, West DS. Patterns of success: 
online self-monitoring in a web-based behavioural weight control program. Health Psychol 
2013 Feb;32(2):164-170. PMID:22545978 
40. Parsons H. What Happened at Hawthorne? New evidence suggests the Hawthorne effect 
resulted from operant reinforcement contingencies. Science 1974 Mar;183(4128):922-932. 
PMID:17756742 
Abbreviations 
 
ANCOVA: analysis of covariance 
BMI: body mass index 
CRP: C-reactive protein 
CVD: cardiovascular disease 
GPPAQ: General Practice Physical Activity Questionnaire 
HDL: high-density lipoprotein 
ITT: Intention-to-treat 
MET: metabolic equivalent 
QUB: Queen’s University Belfast 
RCT: randomised controlled trial 
RPAQ: Recent physical activity questionnaire 
WBP: web-based program 
 
 
